Skin and cutaneous appendices > Skin inflammation and disorders >

Reference Title EndPoint Method
Reference Title EndPoint Method
SEBO3D-00103D sebocytes, lipid accumulation (lipogenic stimulation)*** (must be login)*** (must be login)
SEBO3D-00033D sebocytes, sebocyte differentiation markers (basal)*** (must be login)*** (must be login)
SEBO3D-00013D sebocytes, testosterone metabolism & 5- alpha reductase activity (basal)*** (must be login)*** (must be login)
BIOCH-0025Acellular, TBARS formation*** (must be login)*** (must be login)
DPF-0005DPF, cytokine release ( IL-1 alpha stimulation)IL-6 release
IL-8 release
ELISA / EIA
DPF-0016DPF, estrogen metabolism & aromatase activity (basal)*** (must be login)*** (must be login)
DPF-0023DPF, PGD2 release ( IL-1 alpha stimulation)*** (must be login)*** (must be login)
DPF-0008DPF, PGE2 release ( IL-1 alpha stimulation)*** (must be login)*** (must be login)
DPF-0001DPF, testosterone metabolism & 5- alpha reductase activity (basal)5- alpha reductase activity[14C]-testosterone incorporation
JURK-0003Jurkat cells, lipid peroxide content (UV stimulation)*** (must be login)*** (must be login)
NHDFBACT-0001NHDF, Cytokine/chemokine release (C. acnes stimulation)IL-6 release
IL-8 release
ELISA / EIA
NHDF-0126NHDF, cytokine/chemokine release (flagellin stimulation)*** (must be login)*** (must be login)
NHDFBACT-0004NHDF, Cytokine/chemokine release (P. aeruginosa stimulation)*** (must be login)*** (must be login)
NHDF-0125NHDF, cytokine/chemokine release (poly(I:C) stimulation)*** (must be login)*** (must be login)
NHDFBACT-0005NHDF, Cytokine/chemokine release (S. epidermidis stimulation)*** (must be login)*** (must be login)